ImmunityBio Provides Regulatory Update on Global Submission for ANKTIVA + BCG in BCG …
ImmunityBio, Inc. (NASDAQ: IBRX) today announced the completion of the submissions of its marketing authorization applications (MAA) for ANKTIVA® …Read More
The Heartbeat of World events
ImmunityBio, Inc. (NASDAQ: IBRX) today announced the completion of the submissions of its marketing authorization applications (MAA) for ANKTIVA® …Read More